Alissa Huston
Overview
Explore the profile of Alissa Huston including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
397
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Berman T, Ben-Arye E, Kienle G, Master V, Huston A, Paller C
Clin Cancer Res
. 2025 Feb;
PMID: 40019882
Modern cancer pharmacotherapy consists of contributions from natural products, their structural analogues, and chemotherapies. Interest in natural products is being revitalized in oncology. Natural products may be classified as food,...
2.
Gergelis K, Huston A, OSullivan C, Laack N, Corbin K
Hematol Oncol Clin North Am
. 2025 Jan;
39(2):359-375.
PMID: 39827041
Addressing various dimensions of well-being can help improve oncology patients' symptoms and their overall quality of life (QOL); similar strategies can be used to support caregivers of oncology patients to...
3.
Paschalis K, Marin C, Miller K, Regis C, Bates K, Gooch J, et al.
Ann Surg Oncol
. 2025 Jan;
32(4):2526-2533.
PMID: 39815075
Background: Preventative medication (PM) uptake is low among patients at an elevated risk of breast cancer, largely due to fears of intolerance. This study aimed to investigate whether a new,...
4.
Campbell E, Campbell T, Culakova E, Blanchard L, Wixom N, Guido J, et al.
Breast Cancer Res Treat
. 2024 Mar;
206(2):273-283.
PMID: 38553649
Purpose: Quality of life (QOL) is among the most important outcomes for women with metastatic breast cancer (MBC), and it predicts survival. QOL is negatively impacted by cognitive impairment, fatigue,...
5.
Campbell T, Campbell E, Culakova E, Blanchard L, Wixom N, Guido J, et al.
Breast Cancer Res Treat
. 2024 Mar;
205(2):257-266.
PMID: 38446316
Purpose: Breast cancer treatment is associated with weight gain, and obesity and its related cardiometabolic and hormonal risk factors have been associated with poorer outcomes. Dietary intervention may address these...
6.
Huston A, Leleu X, Jia X, Moreau A, Ngo H, Runnels J, et al.
Clin Cancer Res
. 2024 Feb;
30(4):922.
PMID: 38362725
No abstract available.
7.
Lacey J, Huston A, Lopez G, Ruiz Vozmediano J, Lam C, Narayanan S, et al.
Curr Oncol Rep
. 2024 Feb;
26(3):200-211.
PMID: 38358637
Purpose Of Review: Over the last 2 decades, integrative oncology (IO) has seen exponential growth within cancer care. It aims to combine evidence-based complementary therapies with conventional treatments to improve...
8.
Campbell E, Campbell T, Culakova E, Blanchard L, Wixom N, Guido J, et al.
Res Sq
. 2023 Dec;
PMID: 38045318
Purpose: Quality of life (QOL) is among the most important outcomes for women with metastatic breast cancer (MBC) and it predicts survival. QOL is negatively impacted by cognitive impairment, fatigue,...
9.
Campbell T, Campbell E, Culakova E, Blanchard L, Wixom N, Guido J, et al.
Res Sq
. 2023 Nov;
PMID: 37986940
Purpose: Breast cancer treatment is associated with weight gain, and obesity and its related cardiometabolic and hormonal risk factors have been associated with poorer outcomes. Dietary intervention may address these...
10.
Carlson L, Ismaila N, Addington E, Asher G, Atreya C, Balneaves L, et al.
J Clin Oncol
. 2023 Aug;
41(28):4562-4591.
PMID: 37582238
Purpose: To provide evidence-based recommendations to health care providers on integrative approaches to managing anxiety and depression symptoms in adults living with cancer. Methods: The Society for Integrative Oncology and...